BUZZ-Australia's Optiscan Imaging gains on signing new cross-border research deal

IPATH GS CRUDE OIL TOTAL RET INDEX

IPATH GS CRUDE OIL TOTAL RET INDEX

OIL

0.00

** Shares of Australia's Optiscan Imaging OIL.AX rise as much as 8.9% to A$0.153

** Stock erases most losses from Tuesday's session

** Company signs a research agreement with US-based Mayo Clinic to test its breast cancer imaging platforms

** Study is designed to potentially generate clinical evidence for planned FDA 510(k) submission, company says

** Stock up 50% YTD, including current session's moves


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.